Stay updated on T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial
Sign up to get notified when there's something new on the T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial page.

Latest updates to the T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial page
- CheckyesterdayChange DetectedA new revision v3.5.2 has been added and the previous revision v3.5.0 has been removed.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check30 days agoChange DetectedA new record version v3.5.0 was added and the previous version v3.4.3 was removed from the history.SummaryDifference0.1%

- Check37 days agoChange DetectedRevision: v3.4.3 was added to the history, replacing the previous v3.4.2 entry in the record history.SummaryDifference0.1%

- Check65 days agoChange DetectedAdded Revision: v3.4.2 banner on the page. Removed notices about government funding/operating status and the previous v3.4.1 revision.SummaryDifference0.7%

- Check73 days agoChange DetectedAdded a site-wide funding/operating status notice. Updated the history version from v3.4.0 to v3.4.1.SummaryDifference0.7%

- Check80 days agoChange DetectedThe new version adds a glossary display toggle, color-coded change highlights (green for additions, red for deletions) in the study history, and updates the revision label from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

Stay in the know with updates to T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-Guard vs Ruxolitinib in Acute GvHD Clinical Trial page.